Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Study FOLFIRINOX and NIS793 in Patients With Pancreatic Cancer

NCT05417386 is registered in ClinicalTrials.gov with Colin D. Weekes, M.D., PhD as lead sponsor.

NCT NCT05417386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05417386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Study FOLFIRINOX and NIS793 in Patients With Pancreatic Cancer
Lead sponsor
Colin D. Weekes, M.D., PhD
Phase
Phase 1
Overall status
Terminated
Start date
August 9, 2022
Completion date
July 10, 2023
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic adenocarcinoma, metastatic pancreatic cancer, pancreas cancer